华北制药
(600812)
| 流通市值：99.00亿 | | | 总市值：99.00亿 |
| 流通股本：17.16亿 | | | 总股本：17.16亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,721,574,148.94 | 1,770,138,674.36 | 869,697,786.52 | 988,276,107.83 |
| 应收票据及应收账款 | 2,171,924,917.65 | 2,264,221,256.42 | 2,252,499,234.59 | 1,930,902,848.78 |
| 应收账款 | 2,171,924,917.65 | 2,264,221,256.42 | 2,252,499,234.59 | 1,930,902,848.78 |
| 应收款项融资 | 261,103,108.5 | 199,569,181.33 | 110,980,972.54 | 135,375,613.75 |
| 预付款项 | 257,383,074.89 | 245,353,484.56 | 276,599,840.4 | 282,427,824.35 |
| 其他应收款合计 | 1,643,268,158.02 | 1,499,334,081.64 | 1,619,632,826.21 | 1,902,203,194.48 |
| 其中:应收利息 | 2,224,831.22 | 1,017,592.99 | 6,669,820.78 | 4,834,666.63 |
| 存货 | 2,460,136,846.55 | 2,605,606,932.98 | 2,595,132,697.44 | 2,607,784,499.28 |
| 其他流动资产 | 158,144,411.48 | 167,216,264.76 | 183,233,327.19 | 170,620,975.11 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 8,673,534,666.03 | 8,751,439,876.05 | 7,907,776,684.89 | 8,017,591,063.58 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,234,619,664.01 | 1,223,752,172.58 | 1,209,670,133.05 | 1,202,161,386.57 |
| 其他权益工具投资 | 17,465,000 | 17,465,000 | 17,465,000 | 17,465,000 |
| 固定资产 | 6,517,242,411.08 | 6,642,012,943.79 | 6,575,283,297.49 | 6,446,830,948.81 |
| 在建工程 | 349,270,261.43 | 280,501,629.25 | 219,691,817.18 | 162,346,929.1 |
| 使用权资产 | 408,466,234.58 | 427,768,349.33 | 642,059,973.49 | 922,595,071.13 |
| 无形资产 | 2,210,506,830.56 | 2,096,756,491.89 | 1,942,997,325.9 | 1,974,821,364.14 |
| 开发支出 | 2,185,474,341.39 | 2,200,303,388.17 | 2,253,305,478.02 | 2,104,207,475.46 |
| 商誉 | 3,336,585.26 | 3,336,585.26 | 3,336,585.26 | 3,336,585.26 |
| 长期待摊费用 | 54,765,419.32 | 55,917,448.96 | 52,098,701.54 | 53,234,416.31 |
| 递延所得税资产 | 52,109,827.43 | 52,109,827.43 | 52,109,827.43 | 52,109,827.43 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 13,033,256,575.06 | 12,999,923,836.66 | 12,968,018,139.36 | 12,939,109,004.21 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 21,706,791,241.09 | 21,751,363,712.71 | 20,875,794,824.25 | 20,956,700,067.79 |
| 流动负债: | | | | |
| 短期借款 | 6,756,470,000 | 5,981,085,000 | 5,091,810,000 | 5,467,710,000 |
| 应付票据及应付账款 | 2,583,058,365.41 | 2,720,802,822.13 | 2,582,602,861.53 | 2,489,894,686.93 |
| 其中：应付票据 | 633,245,011.58 | 622,553,682.71 | 581,359,920.4 | 581,040,000 |
| 应付账款 | 1,949,813,353.83 | 2,098,249,139.42 | 2,001,242,941.13 | 1,908,854,686.93 |
| 合同负债 | 258,541,625.59 | 251,719,209.73 | 243,083,499.59 | 313,252,998.29 |
| 应付职工薪酬 | 191,039,501.7 | 187,448,949.95 | 180,395,438.76 | 176,880,926.47 |
| 应交税费 | 67,485,288.16 | 65,766,367.33 | 58,125,236.54 | 63,558,148.55 |
| 其他应付款合计 | 410,586,425.49 | 457,575,144.72 | 458,108,393.43 | 455,541,859.06 |
| 其中:应付利息 | 1,949,524.43 | 19,057.5 | 1,061,118.04 | 997,516.14 |
| 应付股利 | 1,797,687.5 | 18,954,991.2 | 385,687.5 | 385,687.5 |
| 一年内到期的非流动负债 | 791,896,718.01 | 1,708,699,634.63 | 1,150,747,554.55 | 1,299,861,845.99 |
| 其他流动负债 | 18,471,397.6 | 2,074,373.51 | 28,907,423.63 | 1,864,671.35 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 11,077,549,321.96 | 11,375,171,502 | 9,793,780,408.03 | 10,268,565,136.64 |
| 非流动负债: | | | | |
| 长期借款 | 3,841,790,560.64 | 3,623,247,958.57 | 4,486,600,885.84 | 4,080,858,283.77 |
| 租赁负债 | 146,279,993.47 | 163,973,611.69 | 256,571,618.15 | 299,161,001.6 |
| 长期应付款 | 900,000 | 900,000 | 900,000 | 900,000 |
| 递延收益 | 34,687,829.77 | 33,457,729.97 | 34,128,068.66 | 36,805,466.69 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 4,023,658,383.88 | 3,821,579,300.23 | 4,778,200,572.65 | 4,417,724,752.06 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 15,101,207,705.84 | 15,196,750,802.23 | 14,571,980,980.68 | 14,686,289,888.7 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,715,730,370 | 1,715,730,370 | 1,715,730,370 | 1,715,730,370 |
| 资本公积 | 3,862,201,522.06 | 3,859,238,032.3 | 3,899,134,148.47 | 3,899,134,148.47 |
| 其他综合收益 | 6,183,858.59 | 7,126,398.64 | 6,372,523.95 | 6,334,060.15 |
| 专项储备 | 1,553,929.9 | 1,549,440.87 | 1,281,671.48 | 710,521.11 |
| 盈余公积 | 322,436,110.73 | 322,436,110.73 | 322,436,110.73 | 322,436,110.73 |
| 未分配利润 | -543,735,315.87 | -574,214,561.19 | -610,889,206.29 | -629,041,653.38 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,364,370,475.41 | 5,331,865,791.35 | 5,334,065,618.34 | 5,315,303,557.08 |
| 少数股东权益 | 1,241,213,059.84 | 1,222,747,119.13 | 969,748,225.23 | 955,106,622.01 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 6,605,583,535.25 | 6,554,612,910.48 | 6,303,813,843.57 | 6,270,410,179.09 |
| 负债和股东权益合计 | 21,706,791,241.09 | 21,751,363,712.71 | 20,875,794,824.25 | 20,956,700,067.79 |
| 公告日期 | 2024-10-26 | 2024-08-14 | 2024-04-26 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |